DE framework in Large Healthcare Corporations

DiscussionsCategory: The 24 StepsDE framework in Large Healthcare Corporations
Chetan Thakkar asked 3 years ago

Hi,
I am fascinated by Bill Aulet’s drive for making Large Corporations more Entrepreneurial. I work with one such large corporate in healthcare space and would like to know the following:

  • Which are the large healthcare problems that Bill addresses in some of his speeches?
  • Is there a way for individuals to get involved in solving these problems? If so, how?

I look forward to work closely with DE group in the spirit of “Mens et Manus” 🙂

2 Answers
Bill Aulet answered 3 years ago

Healthcare in general falls into 3 broad categories:

  1. Digital Healthcare — companies like PillPack adn Podometrics (which both came out of our center) and many more. that you can find in Hacking Medicine @ MIT. This is generally the digitization of processes in the field to produce better and cheaper positive outcomes.
  2. Medical Devices — this is where there is a physical device that incorporates some advanced technology to improve healthcare.
  3. BioTech — producing new drugs.

All of these areas benefit from the DE approach but from my perspective it applies best to #1 (as seen by the results to date) and then followed by #2 and then #3. Honestly, I don’t completely understand how it applies to #3 but biotech people tell me that it does. 
With regard to #2 above, Paul Yok’s work that he developed in the Stanford BioDesign group has been highly recommended to me and I would look at that as well.
Bill
 
 

Bill Aulet answered 3 years ago

Healthcare in general falls into 3 broad categories:

  1. Digital Healthcare — companies like PillPack adn Podometrics (which both came out of our center) and many more. that you can find in Hacking Medicine @ MIT. This is generally the digitization of processes in the field to produce better and cheaper positive outcomes.
  2. Medical Devices — this is where there is a physical device that incorporates some advanced technology to improve healthcare.
  3. BioTech — producing new drugs.

All of these areas benefit from the DE approach but from my perspective it applies best to #1 (as seen by the results to date) and then followed by #2 and then #3. Honestly, I don’t completely understand how it applies to #3 but biotech people tell me that it does. 
With regard to #2 above, Paul Yok’s work that he developed in the Stanford BioDesign group has been highly recommended to me and I would look at that as well.
Bill
 
 

Your Answer

2 + 18 =